Hanjing Kong1
1Peking University, Beijing, China
Synopsis
Renal embolization is part of a multisystemic disease and has attracted
enhanced attention in recent years for its increasing incidence in the elderly.It is a significant cause
of renal loss in patients who suffer from valvular cardiopathy, aortic
atheromatosis, and hypercoagulable states. In this study,
we attempt to investigate the feasibility of compressed sensing (CS) based
DCE-MRI in the assessment of AERD in animal models.
Introduction
Renal embolization is part of a multisystemic disease and has attracted
enhanced attention in recent years for its increasing incidence in the elderly[1].
It is a significant cause of renal loss in
patients who suffer from valvular cardiopathy, aortic adenomatosis, and
hypercoagulable states[2-5]. The definitive diagnosis is made by
renal biopsy[6]. However, many
patients are too acutely ill to tolerate renal biopsy. In recent years, several imaging methods including radioisotope renogram,
renal angiogram, and contrast-enhanced CT have been applied to aid in the
diagnosis of renal diseases. However, they are
invasive and or have relatively poor sensitivity.
Dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI) has been established as a reliable method for estimating single kidney glomerular filtration rate (GFR) and assessment of renal disease[7]. In this study, we attempt to investigate the
feasibility of compressed sensing (CS) based DCE-MRI in the assessment of renal embolization in animal models.Methods
The in vivo animal experiments were approved by
the Hospital Ethics Committee for Animal Research. Experiments were performed
on 15 male New Zealand White rabbits (weighing 2.8–3.3 kg). Animal models of
unilateral embolization were first conducted. DCE-MRI data were acquired using a GE
3.0T MR scanner (Signa ExciteTM; General Electric Medical Systems, Milwaukee,
WI, USA) with 8-channel TORSOPA coil. The coronal CS DCE-MRI scan was performed
with the following parameters: TR = 3.2 msec / TE = 1.3 msec, flip angle = 12°,
acquisition matrix = 256 × 256 × 12, NEX=1, slice thickness = 4 mm, field of
view = 180mm, CS acceleration factor = 4. In dynamic contrast-enhanced
experiments, five frames of non-enhanced volumes of the kidney were acquired
before the bolus administration. Then, 0.1 mmol/kg bodyweight of Gd-DTPA
(Magnevist, Bayer Schering Pharma AG, Berlin, Germany) was injected, followed
by a 5.0 ml saline flush. Images were acquired immediately and the total scan
time is about 8 minutes for each rabbit.
Results were represented in mean ± standard
deviation (SD). The student t-test was performed to compare the value of GFR
between normal tissue and contra-lateral embolized lesion. P-value < 0.05
was considered statistically significant. Results
A representative CS DCE-MR image and contrast
agent uptake curve in normal kidneys are shown in Fig 1. The detailed spatial
resolution enables the display of the renal parenchyma and renal artery without obvious artifacts. Cortical
ROIs were manually drawn (blue and green circle in Fig 1b) and slice that with
a branch of the renal artery (red circle in Fig 1d) was selected
for aortic ROI drawing. Representative concentration curves at a temporal
resolution of 2.5s derived from corresponding ROIs are shown in Fig 1
e,f.
Representative GFR map and corresponding concentration curves
derived from cortical and medullary ROIs are shown in Fig 2 a,b.
GFR reduction regions on the GFR map (Fig 2a) matched closely to the heavily
embolized regions in the renal specimen (Fig 2c), but the lesion region in the GFR
map showed a certain degree of underestimation compared with the specimen. In
histological findings (Fig 2d), the glomeruli showed ischemic and wrinkled
features with thickening change of Bowman’s capsule, and necrosis
of the renal tubular epithelial cells was observed, the
basement membrane was exposed. Meanwhile, the brush border of some tubular
epithelial cells fell off and the tubular epithelial cells became flat and
tubular lumen expanded.
A total of 17 lesions was found in all rabbits by the renal specimen and
confirmed by histological findings. 14 lesions were found by CS DCE-MRI and the
lesion size is 0.14 ± 0.07 cm2. For the GFR comparison, GFR of the embolized
lesion was significantly lower than GFR of normal tissue (0.0038 ±
0.005 ml/min vs 0.0075 ± 0.0008 ml/min, P<0.0001) in Fig 3. Discussion
Once the emboli enter
the blood circulation, it will stay in a small artery about 150-200 μm in
diameter[9] and further causing small artery occlusion and
inflammation. The focal feature of embolization, placing a greater demand on the spatial
resolution of imaging modality. In this study, the spatial resolution of CS DCE-MRI is 0.7mm*0.7mm. The
high resolution and reduced partial volume effect enabled precise visualization
of lesion and detection of a majority of lesions (14/17).
In this study, a temporal resolution of 2.5s was achieved and was
adequate for renal DCE-MRI. By utilizing a well-established cortical
compartment model[10, 11], the GFR values estimated normal kidneys with
high reproducibility were close to literature reports[8, 10], which suggested that this method was able
to provide reliable GFR measurements. Conclusion
In conclusion, this preliminary animal study
demonstrated the feasibility of using the CS DCE-MRI in quantitative renal
function evaluation, with satisfactory reproducibility. The efficacy was
carefully verified by histology findings. This CS DCE-MRI could potentially provide a valuable tool to identify renal embolization and monitor the success of therapeutic methods in clinical practice.Acknowledgements
No acknowledgement found.References
[1] SCOLARI
F, RAVANI P. Atheroembolic renal disease [J]. The Lancet, 2010, 375(9726):
1650-60.
[2] FORT
J. Renal artery embolism [J]. Renal Failure, 1997, 19(6): R7-R8.
[3] NICHOLAS
G G, DEMUTH W E. Treatment of Renal-Artery Embolism [J]. Arch Surg-Chicago,
1984, 119(3): 278-81.
[4] KORZETS
Z, PLOTKIN E, BERNHEIM J, et al. The clinical spectrum of acute renal
infarction [J]. Isr Med Assoc J, 2002, 4(10): 781-4.
[5] KANSAL
S, FELDMAN M, COOKSEY S, et al. Renal artery embolism - A case report and
review [J]. J Gen Intern Med, 2008, 23(5): 644-7.
[6] WILSON
D M, SALAZER T L, FARKOUH M E. Eosinophiluria in atheroembolic renal disease
[J]. The American journal of medicine, 1991, 91(2): 186-9.
[7] HAHN
O M, YANG C, MEDVED M, et al. Dynamic Contrast-Enhanced Magnetic Resonance
Imaging Pharmacodynamic Biomarker Study of Sorafenib in Metastatic Renal
Carcinoma [J]. Journal of Clinical Oncology, 2008, 26(28): 4572-8.
[8] CHEN
B, ZHANG Y, SONG X, et al. Quantitative estimation of renal function with
dynamic contrast-enhanced MRI using a modified two-compartment model [J]. PloS
one, 2014, 9(8): e105087.
[9] ELIOT
R S, EDWARDS J E, KANJUH V I. Atheromatous Embolism [J]. Circulation, 1964,
30(4): 611-&.
[10] ANNET
L, HERMOYE L, PEETERS F, et al. Glomerular filtration rate: Assessment with
dynamic contrast-enhanced MRI and a cortical-compartment model in the rabbit
kidney [J]. Journal of Magnetic Resonance Imaging, 2004, 20(5): 843-9.
[11] BUCKLEY
D L, SHURRAB A E, CHEUNG C M, et al. Measurement of single kidney function
using dynamic contrast-enhanced MRI: Comparison of two models in human subjects
[J]. Journal of Magnetic Resonance Imaging, 2006, 24(5): 1117-23.